The Role of 15-Lipoxygenase-1- and Cyclooxygenase-2-Derived Lipid Mediators in Endothelial Cell Proliferation
dc.contributor.advisor | Dr. Ian A. Blair | |
dc.contributor.author | Wei, Cong | |
dc.date | 2023-05-17T03:48:15.000 | |
dc.date.accessioned | 2023-05-22T16:59:45Z | |
dc.date.available | 2010-07-07T00:00:00Z | |
dc.date.issued | 2010-08-13 | |
dc.date.submitted | 2010-07-07T12:00:02-07:00 | |
dc.description.abstract | It is a generally accepted paradigm that there is a direct link between inflammation and tumor progression. During inflammation, there is increased formation of lipid hydroperoxides, mediated either non-enzymatically by reactive oxygen species or enzymatically by lipoxygenases (LOs) or cyclooxygenases (COXs). Lipid hydroperoxides undergo further oxidation into oxo-eicosatetraenoic acids (oxo-ETEs), which are produced and released by cells including macrophages and epithelial cells. Therefore, these oxo-ETEs could potentially mediate biological effects in an autocrine and/or a paracrine manner. In addition, oxo-ETEs conjugate intracellular glutathione (GSH) to form adducts which could serve as biomarkers of oxo-ETE formation. In this study, a targeted lipidomics approach combined with stable isotope dilution methodology was employed to identify and quantify lipid hydroperoxides and their metabolites formed in 15-LO-expressing mouse macrophage cell line (R15L cells) and COX-2 expressing cell models (RIES cells and Caco-2 cells) as well as in mouse hematocytes and primary human monocytes. 15-Oxo-5,8,11,13-(Z,Z,Z,E)-ETE (15-oxo-ETE) was identified and characterized as a major eicosanoid produced in both mouse and human macrophage 15-LO pathway. 15-Oxo-ETE was shown to be a metabolite of arachidonic acid (AA)-derived 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) by 15-hydroxyprostaglandin dehydrogenase (15-PGDH). A novel biological activity of 15-oxo-ETE was revealed, which involved inhibition of human umbilical vein endothelial cell (HUVEC) proliferation by suppressing DNA synthesis, implicating a potential anti-angiogenic role of 15-oxo-ETE. In addition to 15-oxo-ETE, another AA-derived eicosanoid 11-oxo-5,8,12,14-(Z,Z,E,Z)-eicosatetraenoic acid (11-oxo-ETE), was identified as a major metabolite arising from COX-2-derived from 11(R)-hydroxyl-5,8,12,14-(Z,Z,E,Z)-eicosatetraenoic acid (11(R)-HETE) in both rat (RIES) and human (Caco-2) epithelial cell lines. A specific liquid chromatography-multiple reaction monitoring mass spectrometry (LC-MRM/MS) method revealed that both 11-oxo-ETE and 15-oxo-ETE were secreted in nM concentrations when AA was added to RIES and human Caco-2 cells. Surprisingly, 11(R)-HETE was an excellent substrate for 15-PGDH, with a catalytic efficiency similar to that found for 15(S)-HETE. In addition, it was demonstrated that aspirin significantly stimulated the production of 15(R)-HETE, which was then converted to 15-oxo-ETE by an unknown dehydrogenase (DH). These findings could have significant clinical implications since 15-PGDH is down-regulated during carcinogenesis, which in addition to increasing the pro-proliferative activity of PGE2 would prevent the formation of anti-proliferative 15-oxo-ETE from 15(S)-HETE. However, the formation of 15-oxo-ETE from 15(R)-HETE after aspirin treatment, through a pathway that does not involve 15-PGDH, could help counteract the increased pro-proliferative activity of PGE2. | |
dc.description.degree | Doctor of Philosophy (PhD) | |
dc.identifier.uri | https://repository.upenn.edu/handle/20.500.14332/29081 | |
dc.legacy.articleid | 1265 | |
dc.legacy.fulltexturl | https://repository.upenn.edu/cgi/viewcontent.cgi?article=1265&context=edissertations&unstamped=1 | |
dc.source.issue | 219 | |
dc.source.journal | Publicly Accessible Penn Dissertations | |
dc.source.status | published | |
dc.subject.other | LIPID MEDIATORS | |
dc.subject.other | 15-LIPOXYGENASE-1 | |
dc.subject.other | CYCLOOXYGENASE-2 | |
dc.subject.other | ENDOTHELIAL CELL PROLIFERATION | |
dc.subject.other | 15-OXO-ETE | |
dc.subject.other | 11-OXO-ETE | |
dc.subject.other | Medicinal Chemistry and Pharmaceutics | |
dc.subject.other | Pharmacology | |
dc.title | The Role of 15-Lipoxygenase-1- and Cyclooxygenase-2-Derived Lipid Mediators in Endothelial Cell Proliferation | |
dc.type | Dissertation/Thesis | |
digcom.date.embargo | 2010-07-07T00:00:00-07:00 | |
digcom.identifier | edissertations/219 | |
digcom.identifier.contextkey | 1385106 | |
digcom.identifier.submissionpath | edissertations/219 | |
digcom.type | dissertation | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | c591d79f-9d97-4bd2-9f4d-c53ab5034f32 | |
relation.isAuthorOfPublication.latestForDiscovery | c591d79f-9d97-4bd2-9f4d-c53ab5034f32 |
Files
Original bundle
1 - 1 of 1